111962-90-4 Usage
Uses
Used in Pharmaceutical Applications:
6-Benzothiazolecarboxamide,2-amino-(9CI) is utilized as a key intermediate in the synthesis of various pharmaceutical compounds. Its unique structure and biological activity make it a valuable component in the development of new drugs, particularly those targeting specific therapeutic areas.
Used in Agrochemical Applications:
In the agrochemical industry, 6-Benzothiazolecarboxamide,2-amino-(9CI) serves as a building block for the creation of novel agrochemical products. Its properties contribute to the formulation of effective pesticides, herbicides, and other crop protection agents, enhancing agricultural productivity and crop protection.
Used in Dye Industry:
6-Benzothiazolecarboxamide,2-amino-(9CI) is employed as a dyestuff in the production of various types of dyes. 6-Benzothiazolecarboxamide,2-amino-(9CI)'s chemical structure allows for the creation of dyes with specific color characteristics and properties, catering to the needs of different industries such as textiles, plastics, and printing.
Used in Scientific Research:
6-Benzothiazolecarboxamide,2-amino-(9CI) is a vital component in various scientific research studies. Its role in research extends to the exploration of its chemical properties, potential biological activities, and applications in the synthesis of complex molecules, contributing to the advancement of knowledge in chemistry and related fields.
Check Digit Verification of cas no
The CAS Registry Mumber 111962-90-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,1,9,6 and 2 respectively; the second part has 2 digits, 9 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 111962-90:
(8*1)+(7*1)+(6*1)+(5*9)+(4*6)+(3*2)+(2*9)+(1*0)=114
114 % 10 = 4
So 111962-90-4 is a valid CAS Registry Number.
111962-90-4Relevant articles and documents
Probing the ATP-Binding Pocket of Protein Kinase DYRK1A with Benzothiazole Fragment Molecules
Rothweiler, Ulli,Stensen, Wenche,Brandsdal, Bj?rn Olav,Isaksson, Johan,Leeson, Frederick Alan,Engh, Richard Alan,Svendsen, John S. Mj?en
, p. 9814 - 9824 (2016/11/19)
DYRK1A has emerged as a potential target for therapies of Alzheimer's disease using small molecules. On the basis of the observation of selective DYRK1A inhibition by firefly d-luciferin, we have explored static and dynamic structural properties of fragment sized variants of the benzothiazole scaffold with respect to DYRK1A using X-ray crystallography and NMR techniques. The compounds have excellent ligand efficiencies and show a remarkable diversity of binding modes in dynamic equilibrium. Binding geometries are determined in part by interactions often considered "weak", including "orthogonal multipolar" types represented by, for example, F-CO, sulfur-aromatic, and halogen-aromatic interactions, together with hydrogen bonds that are modulated by variation of electron withdrawing groups. These studies show how the benzothiazole scaffold is highly promising for the development of therapeutic DYRK1A inhibitors. In addition, the subtleties of the binding interactions, including dynamics, show how full structural studies are required to fully interpret the essential physical determinants of binding.